Represents the additional term provided for standard-of-care treatment under collaborative agreement.

No definition available.

Name:	rdus_CollaborativeAgreementAdditionalTermProvidedForStandardOfCareTreatment
Namespace Prefix:	rdus_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the amount of euro-denominated payments required over the course of the Clinical Study under the collaborative agreement.

+ References

No definition available.

+ Details

Name:	rdus_CollaborativeAgreementAmountOfEuroDenominatedPaymentsRequiredOverCourseOfClinicalStudy
Namespace Prefix:	rdus_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the amount of U.S. dollar-denominated payments required over the course of the Clinical Study under the collaborative agreement.

+ References

No definition available.

+ Details

Name:	rdus_CollaborativeAgreementAmountOfUSDollarDenominatedPaymentsRequiredOverCourseOfClinicalStudy
Namespace Prefix:	rdus_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Collaborative Agreement Initial Term Provided for Standard of Care Treatment

+ References

No definition available.

+ Details

Name:	rdus_CollaborativeAgreementInitialTermProvidedforStandardofCareTreatment
Namespace Prefix:	rdus_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rdus_CollaborativeArrangementsTypeOfAgreementAxis=rdus_LetterOfIntentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rdus_ClinicalStudyByPhaseAxis=rdus_AbaloparatideSCPhase3ClinicalExtensionStudyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=rdus_NordicMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rdus_CollaborativeArrangementsTypeOfAgreementAxis=rdus_WorkStatementNB3AmendmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rdus_CollaborativeArrangementsTypeOfAgreementAxis=rdus_WorkStatementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	rdus_ClinicalStudyByPhaseAxis=rdus_AbaloparatideSCPhase3ClinicalSecondExtensionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Research Agreements (Details) - Clinical Trial Services Agreement - Nordic € in Millions, $ in Millions	1 Months Ended		12 Months Ended
	Apr. 30, 2015 USD ($)	Apr. 30, 2015 EUR (€)	Dec. 31, 2017 USD ($)	Dec. 31, 2017 EUR (€)
Letter of Intent \| Abaloparatide-SC Phase 3 Extension Clinical Study
Research Agreements
Initial term provided for standard of care treatment			6 months	6 months
Additional term provided for standard-of-care treatment			18 months	18 months
NB-3 Amendment \| Abaloparatide-SC Phase 3 Extension Clinical Study
Research Agreements
Amount of euro-denominated payments required over the course of clinical trial	$ 4.3	€ 4.1
Clinical Trial Services Agreement \| Abaloparatide-SC Phase 3 Extension Clinical Study
Research Agreements
Amount of euro-denominated payments required over the course of clinical trial			$ 12.5	€ 11.9
Clinical Trial Services Agreement \| Abaloparatide-SC Phase3 Clinical Second Extension
Research Agreements
Amount of U.S. dollar-denominated payments required over the course of clinical trial			$ 1.1